Publication: 4077

Publication: 4077

Evaluating the utility of ZNF331 promoter methylation as a prognostic and predictive marker in stage III colon cancer: results from CALGB 89803 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Epigenetics vol 19 (1)

Year:: 2024
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub-ppub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: Yes
Book Volume:: 13

Parents:: 3891
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U24CA196171, UG1CA233180, UG1CA233328, UG1CA233339, UG1CA233373; P30-CA015704-44, R50CA233042, T32 CA009515, P30CA15704, UO1CA152756, RO1CA220004, UO1AG077920, U2CCA271902

Corr. Author:
Authors:: Elizabeth S. Nakasone Tyler J. Zemla Ming Yu She Yu Lin Fang-Shu Ou Kelly Carter Federico Innocenti Leonard Saltz William M. Grady Stacey A. Cohen

Networks:: HAWAII, LAPS-MN026, LAPS-NC007, LAPS-NY016, NY167

Study: CALGB-89803
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: